Significant mRNA expression differences in immune checkpoint receptors LAG3, PD1, CTLA4, CD28, ICOS, BTLA, and HAVCR2 between high expression of HK2 and low expression of HK2 were depicted in RCC patients. Here, HK2 is linked to renal cell carcinoma.